Cell Signaling Technology

Phospho-Ack1 (Tyr284) Antibody

#3138 · $453

100
Citing papers
16k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer10Cell death mechanisms and regulation9Cancer-related Molecular Pathways8MicroRNA in disease regulation6Endoplasmic Reticulum Stress and Disease5Inflammasome and immune disorders5Autophagy in Disease and Therapy5DNA Repair Mechanisms5

Papers citing this product

1
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
Cell Research·2019·1.4k cit.·DOI
2
Tau protein liquid–liquid phase separation can initiate tau aggregation
The EMBO Journal·2018·1.1k cit.·DOI
3
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
Blood·2008·777 cit.·DOI
4
Specific MicroRNAs Modulate Embryonic Stem Cell–Derived Neurogenesis
Stem Cells·2005·676 cit.·DOI
5
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
The EMBO Journal·2006·525 cit.·DOI
6
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1–phosphate receptor-1 crossactivation
Blood·2004·470 cit.·DOI
7
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
Stem Cells·2016·344 cit.·DOI
8
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
British Journal of Cancer·2008·317 cit.·DOI
9
Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
American Journal Of Pathology·2012·274 cit.·DOI
10
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
Genes & Development·2011·259 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.